Search
Filter Results
Displaying 371–380 of 723 for “Visions 2020”
-
Jan 18, 2022
Survey results will inform therapy developers and the agenda for a Patient-Focused Drug Development meeting with Food and Drug Administration representatives.
-
Dec 22, 2021
Organizations collaborate on inherited macular dystrophy program
The Foundation Fighting Blindness and the Nixon Visions Foundation are working together to launch the Nixon Visions Foundation Inherited Macular Dystrophy Program, according to a news release from the organizations.
-
Our new 2021 PSA campaign, “Together, We’re Winning,” showcases how four individuals living with vision loss continue to ‘win’ on their own terms, by living rich and full lives every day. Lachi, Beverley, Fai, and Mark are all active members of the Foundation Fighting Blindness community and Lulie’s Next Chapter network, and each maintains a positive attitude and winning spirit.
-
Aug 4, 2021
Pediatric Ophthalmologists Target Inherited Retinal Diseases
New opportunities continue to develop in an evolving landscape.
-
May 10, 2021
AGTC Continues to Report Encouraging Data from its Phase 1/2 XLRP Gene Therapy Clinical Trial
The company is planning the launch of a Phase 2/3 trial for its XLRP gene therapy
-
The Eye on the Cure Podcast from the Foundation Fighting Blindness provides science information, news, and insights from the world of vision and retinal diseases. With our Beacon Stories Podcast, we share individual’s journeys with their disease and how their drive fuels them to pursue their passions. Research News Podcast provide updates on News and information on a wide range of topics and subjects.
-
Sep 24, 2020
The event will review best practices for care and management of patients with inherited retinal diseases such as retinitis pigmentosa, Usher syndrome, and Stargardt disease.
-
May 13, 2020
jCyte Enters into Licensing Agreement with Santen Pharmaceutical for Cell Therapy
Emerging treatment designed to preserve vision for people with RP and related conditions
-
Apr 22, 2020
The inaugural credit-based event will include education on inherited retinal diseases, physician resources, and current clinical trials.
-
Apr 1, 2020
Interim Results Released for USH2A RNA Therapy Clinical Trial
Suggestions of efficacy observed in 25 percent of participants receiving the treatment